Summary: H.R.3327 — 116th Congress (2019-2020)All Information (Except Text)

There is one summary for H.R.3327. Bill summaries are authored by CRS.

Shown Here:
Introduced in House (06/18/2019)

Drug Price Transparency for Medicare Patients Act of 2019

This bill provides statutory authority for the Centers for Medicare & Medicaid Services rule titled "Medicare and Medicaid Programs; Regulation to Require Drug Pricing Transparency," published on May 10, 2019. The rule requires direct-to-consumer television advertisements for covered drugs and biologics under Medicare and Medicaid to include the list price of a 30-day supply or for a typical course of treatment, if the list price is at least $35 per month. The rule takes effect July 9, 2019.